Question 1

What are the potential benefits of participating in this trial compared to standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) clinical trial (NCT07231952). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the combination of these three drugs be administered?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) clinical trial (NCT07231952). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) clinical trial (NCT07231952). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) clinical trial (NCT07231952). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests will be required to monitor my health during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) clinical trial (NCT07231952). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks associated with the specific drugs being tested?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) clinical trial (NCT07231952). Contact the study team or your healthcare provider for specific answers.

What this study is about